Fed Sparks Profit T...
Health Care: Drugs
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$8.30 0.24 | 2.99%
05/24/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 156.09M | 57.63M | 150.67M | 94.73M |
| Receivables | 5.56M | 607.00K | 3.50M | 1.42M |
| Inventories | 6.06M | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 171.16M | 60.26M | 156.81M | 121.27M |
| Property, Plant & Equipment, Gross | 159.33M | 157.33M | 158.25M | 154.44M |
| Accumulated Depreciation & Depletion | 83.92M | 75.26M | 66.72M | 59.00M |
| Property, Plant & Equipment, Net | 75.42M | 82.07M | 91.53M | 95.44M |
| Intangibles | 10.61M | 11.03M | 12.03M | 13.12M |
| Other Non-Current Assets | 4.02M | 3.77M | 5.99M | 6.44M |
| Total Non-Current Assets | 90.05M | 96.87M | 109.56M | 115.00M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 261.21M | 157.13M | 266.36M | 236.28M |
| Accounts Payable | 3.88M | 2.36M | 5.02M | 9.68M |
| Short Term Debt | 1.66M | 1.31M | 18.78M | 717.00K |
| Other Current Liabilities | 3.07M | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 29.91M | 14.36M | 36.87M | 20.69M |
| Long Term Debt | 0.00 | 14.70M | 27.40M | 57.05M |
| Deferred Income Taxes | 122.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 59.74M | 43.05M | 46.31M | 7.21M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 132.65M | 132.21M | 149.48M | 141.02M |
| Total Liabilities | 162.57M | 146.57M | 186.35M | 161.71M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 98.64M | 10.56M | 80.02M | 74.57M |
| Common Par | 22.00K | 15.00K | 12.00K | 10.00K |
| Additional Paid In Capital | 1.28B | 1.11B | 1.09B | 961.27M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -1.19B | -1.08B | -989.12M | -864.59M |
| Treasury Stock | 0.00 | -23.07M | -23.07M | -23.07M |
| Other Equity Adjustments | 5.49M | 4.74M | 4.97M | 945.00K |
| Total Capitalization | 98.64M | 25.26M | 107.42M | 131.62M |
| Total Equity | 98.64M | 10.56M | 80.02M | 74.57M |
| Total Liabilities & Stock Equity | 261.21M | 157.13M | 266.36M | 236.28M |
| Total Common Shares Outstanding | 217.48M | 146.09M | 121.52M | 92.81M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 3.00M | 3.00M | 3.00M |
| Basic Weighted Shares Outstanding | 196.52M | 139.17M | 109.57M | 84.34M |
| Diluted Weighted Shares Outstanding | 196.52M | 139.17M | 109.57M | 84.34M |
| Number of Employees | 293 | 266 | 351 | 358 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Watch List
- Usermichelle
- User2012 picks 10/28/20121
- Usermine
- ContributorStocks Under-$10 Moving Hig...
- UserMy SP portfolio
- UserMyfuture
- ContributorStocks Under-$10 Setting Up...
Latest ARNA Headlines from TheStreet
- Happy Day for Arena Bulls, Bears As Belviq Launch Finally Arrives 05.07.13 | 11:05 am
- Arena Stock Gaps Down On Today's Open (ARNA) 05.03.13 | 09:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Large Vivus Shareholder Seeks More Change 04.10.13 | 10:04 am
- Arena Bulls, Bears Endure Annoyingly Long Wait for Belviq Launch 04.10.13 | 09:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Vivus Piles New Debt On Top Of Excuses 03.26.13 | 10:03 am
- Arena Pharmaceuticals Inc. (ARNA): Health Care's Featured Stock Of The Day 03.25.13 | 05:03 pm
- 2 Drug Stocks Under $10 To Pick As Favorites 03.25.13 | 02:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
Press Releases for ARNA
- Pill Economics - Research Report On Arena Pharmaceuticals, Inc. And Amgen, Inc. - PR Newswire 01.23.13 | 08:01 am
- Stock Alerts For Coca-Cola, Deere, News Corp., Arena Pharmaceuticals, And American Tower Released By InvestorsObserver - PR Newswire 06.28.12 | 09:06 am
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- Fannie Mae And Freddie Mac, Short-Term Trade Or Deep Value Investment? - Seeking Alpha 03.25.13 | 09:03 am
- A Look At 3 Obesity Stocks - Seeking Alpha 03.05.13 | 09:03 am
- Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha 03.05.13 | 09:03 am
- Pre-Market Earnings Report for March 4, 2013 : RIG, SSYS, TECD, ARNA, CEL, BYD, YGE, ALVR - NASDAQ 03.01.13 | 09:03 pm
- Arena's Recent Outperform Call And A Probability Weighted Valuation - Seeking Alpha 02.08.13 | 08:02 am
- Arena Must Wait For European Approval - Seeking Alpha 01.19.13 | 07:01 am
- Orexigen: The Best Bet In Obesity For 2013 - Seeking Alpha 12.17.12 | 09:12 am
- Arena Opening New Doors - Seeking Alpha 11.29.12 | 09:11 am
